Amarin Neuroscience Ltd
Quick facts
Phase 3 pipeline
- Ethyl-EPA (Miraxion™) · Cardiovascular
Ethyl-EPA is an ethyl ester of eicosapentaenoic acid (EPA) that reduces triglycerides and modulates lipid metabolism through omega-3 fatty acid supplementation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: